Compound brain protein hydrolysate tablets
Function and Efficacy
Pharmacology: This product can increase the content of neurotransmitters Ach, NA, DA and 5-HT in the brain; increase the density of the capillary network in the brain of young animals and promote the differentiation of animal brain nerve cells; stimulate the diencephalon-pituitary system to release growth hormone and thyroxine to promote the growth and development of animals; improve the amino acid metabolism of brain cells and promote protein synthesis; promote the normalization of glucose transport; improve the brain's ability to resist ischemia and hypoxia; provide precursors of neurotransmitters, peptide hormones and coenzymes; activate adenylate cyclase and catalyze other hormone systems; improve memory, dilate cerebral blood vessels, and improve cerebral blood circulation.
Ingredients
Brain protein hydrolysate, glutamic acid, chondroitin sulfate, vitamin B1, vitamin B6.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| L-Glutamic acidIngredients |
Promotes normalization of glucose transport; improves memory, dilates cerebral blood vessels, and improves cerebral blood circulation More |
56-86-0 | 17 | |
| Chondroitin 4-sulfateIngredients |
Increase the density of capillary networks in the brains of young animals and promote the differentiation of animal brain nerve cells More |
9007-28-7 | 2 | |
| Thiamine chlorideIngredients |
Improve the brain's ability to resist ischemia and hypoxia More |
59-43-8 | 9 | |
| Vitamin B6Ingredients |
Stimulate the diencephalon-pituitary system to release growth hormone and thyroid hormone to promote the growth and development of animals; increase the content of neurotransmitters Ach, NA, DA and 5-HT in the brain More |
8059-24-3 | 12 |
Appearance
This product is a sugar-coated tablet or a film-coated tablet, which is light yellow or brownish yellow after removing the coating.
Indication
It is used to improve the symptoms of craniocerebral trauma, cerebrovascular disease sequelae accompanied by memory loss and attention disorder. It has an auxiliary improvement effect on brain dysfunction, and is also used for patients with protein deficiency, neurasthenia and general protein digestion and absorption disorders.
Usage and Dosage
Oral administration. 3 times a day, 4 tablets each time for adults, and less for children or as directed by a doctor.
Adverse Reactions
No adverse reactions have been reported.
Precautions
1. It is forbidden to use in patients with epilepsy. 2. It is forbidden to use in patients with severe renal dysfunction. 3. It is forbidden to use in patients who are allergic to this product. 4. It is forbidden to use in pregnant and lactating women.
Special Population Medication
Precautions for children: Reduce dosage for children or follow doctor's advice. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: Follow doctor's advice.
Drug Interactions
1 When taking it with antidepressants, it is recommended to reduce the latter dose. 2 When taking monoamine oxidase inhibitors at the same time, the drug effects will be additive.
Storage
Sealed, store in a cool, dry place.
Packaging Specification
Compound
Validity Period
24 months.
Manufacturer
Changchun Norman Bethune Pharmaceutical Co., Ltd.
-
Founded in:
1985-12-06 -
Address:
No. 358, Chuangxin Road, High-tech Industrial Development Zone, Changchun City, Jilin Province -
Tax NO.:
91220101123997525C -
Registered Funds:
64.4778 million yuan -
Website:
-
Email: